Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

Heart failure (HF) remains a major cause of morbidity and mortality. Heart transplantation
(HT) is a life-saving procedure for patients with advanced heart failure, but availability is …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

Objectives: The purpose of this study was to determine the risk factors for ischemic in
hemorrhage cerebrovascular events in patients supported by the HeartWare ventricular …

The drive-line to power contemporary ventricular assist devices exiting the skin is associated
with infection, and requires a holstered performance of the cardiac pump, which reduces …

Mechanical circulatory support devices have become an important treatment tool for severe
acute and chronic heart failure, since heart transplantation cannot meet the demands …

Left ventricular assist devices (LVADs) are becoming a more frequent life-support
intervention. Gaining an understanding of risk factors for infection and management …

Background—Conveying the complex trade-offs of continuous-flow left ventricular assist
devices is challenging and made more difficult by absence of an evidence summary for the …

Objectives We review differences in the incidence and timing of adverse events in patients
implanted with continuous-flow left ventricular assist devices (LVADs), using the Mechanical …

Introduction End stage heart failure is associated with high mortality. However, recent
developments such as the ventricular assist device (VAD) have improved patient outcomes …